Home / Generics

Generics

News

Teva launches first Truvada and Atripla generics and two digital inhalers posted 20/11/2020

On 2 October 2020, Teva Pharmaceuticals announced the launch of the first US Food and Drug Administration (FDA) approved gene...

EMA recommends approval of Lenalidomide Mylan posted 13/11/2020

The European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 15 October 2020 that...

COVID-19 vaccine progress and FDA approvals for Zydus Cadila posted 13/11/2020

India-based generics company, Zydus Cadila, has had many advancements with product development and approval between August an...

FDA approves Glenmark and Cipla generics posted 30/10/2020

Glenmark Pharmaceuticals and Cipla Limited have announced that they have received US food and Drug Administration (FDA) appro...

Sun Pharma launches Ilumya in Japan and favipiravir in India posted 19/10/2020

Sun Pharmaceutical Industries Inc (Sun Pharma) announced that their innovative biopharmaceutical product, Ilumya (tildrakizum...

 

Research

Perspectives of prescribing practices in public health facilities in Eswatini posted 20/01/2021

Rational medicines use (RMU) is the prescribing/dispensing of good quality medicines to meet individual patient’s clinical ne...

Familiarity with substitution of prescription generics increases positive attitudes toward OTC generics posted 11/12/2020

Introduction of measures to stimulate increased sale of generics swept over the Nordic countries in the 2000s. In Sweden, in...

Cost savings after switching to generic tacrolimus posted 04/12/2020

The use of narrow therapeutic index generic immunosuppressant in solid organ transplantation is controversial. This is becaus...

Equivalent adherence with brand and generic osteoporosis treatments posted 27/11/2020

Osteoporosis patients are just as likely to adhere to a generic bisphosphonate treatment as they are to a brand-name product,...

Pharmacokinetics and generic drug switching: a regulators view posted 18/11/2020

Researchers from the Netherlands share their view on the pharmacokinetic aspects of generic drug switching, from a regulatory...

 

General

16704526_l A European pharmaceutical strategy promoting generics and biosimilars posted 08/01/2021

The European Commission has adopted a new Pharmaceutical Strategy for Europe [1], as of 25 November 2020.

Pfizer sues Aurobindo and Dr Reddy’s over Ibrance (palbociclib) generics posted 27/11/2020

US-based pharmaceutical company, Pfizer, has filed petitions in US courts against Aurobindo Pharma and Dr Reddy’s Laboratories.

China prioritizes drug innovation while increasing access to drugs approved abroad posted 26/11/2020

China's pharmaceutical industry is undergoing a transformation towards high-quality and innovation-focused development, which...

Brazil sees a COVID vaccine setback but treatment advancement posted 06/11/2020

In Brazil’s quest to tackle the COVID-19 pandemic, there has been a volunteer death in a potential vaccine trial, but a poten...

Reforms to health policy needed in Europe posted 23/10/2020

The President of Medicines for Europe has made four key recommendations for European Union (EU) pharmaceutical policy,  ...

Generics News Research General

more

Biosimilars News Research General

more